Imexon

Imexon

Systematic (IUPAC) name
4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
Clinical data
Identifiers
CAS Registry Number	59643-91-3 Y
ATC code	None
PubChem	CID 68791
ChemSpider	62031 N
UNII	8F63U28T2V Y
KEGG	D08932 Y
Chemical data
Formula	C4H5N3O
Molecular mass	111.102 g/mol
SMILES O=C1/N=C(/N)C2N1C2
InChI InChI=1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8)  N Key:BIXBBIPTYBJTRY-UHFFFAOYSA-N  N
N (what is this?)  (verify)

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

External links

• Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".